We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Electrostatic-Based DNA Microarray Technique Simplified for Diagnostics

By Labmedica staff writers
Posted on 07 Jul 2008
A technique has been developed in which DNA or RNA assays, which are used for disease detection and genetic profiling, can be read and evaluated without the need of elaborate chemical labeling or sophisticated instrumentation. More...


The technique is relatively simple and is based on electrostatic repulsion in which objects with the same electrical charge repel one another. Inexpensive to implement, the technique can be carried out in a matter of minutes.

A fluid containing thousands of electrically charged microscopic beads or spheres made of silica (glass) is dispersed across the surface of a DNA microarray and the Brownian motion of the spheres provides measurements of the electrical charges of the DNA molecules. The measurements are then used to interrogate millions of DNA sequences at a time. These measurements can be observed and recorded with a simple hand-held imaging device--even a cell phone camera will do.

One of the most amazing things about our electrostatic detection method is that it requires nothing more than the naked eye to read out results that currently require chemical labeling and confocal laser scanners, said Professor Jay Groves, a chemist with joint appointments at Berkeley lab's physical biosciences division (CA, USA) and the chemistry department of the University of California at Berkeley (UC; CA, USA), who led team that developed the technique. We believe this technique could revolutionize the use of DNA microarrays for both diagnostics and research.

Until now, the use of DNA microarray assays has been limited because current techniques typically depend upon fluorescence detection, a demanding methodology that requires time-consuming chemical labeling, high-power excitation sources, and sophisticated instrumentation for scanning. Such demands are generally well beyond the capabilities of individual laboratories or clinics, especially in developing countries. While label-free DNA detection strategies do exist, they require either complex device fabrication or sophisticated instrumentation for readouts. None are compatible with conventional DNA microarrays, where up to one million sequences are available for interrogation in a single experiment.

We have demonstrated parallel sampling of a microarray surface with micron-scale resolutions over centimeter-scale lengths, said Professor Groves. This is four orders of magnitude larger than what has been achieved to date with conventional scanning-electrostatic-force microscopy.

The technique was described in the June 2008 online edition of Nature Biotechnology.


Related Links:
Berkeley Lab's Physical Biosciences Division
Chemistry Department of the University of California at Berkeley

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.